Last updated: February 21, 2026
What is the scope of patent WO2022032141?
WO2022032141, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical composition. It covers a specific compound or combination, along with methods of manufacturing, use, or formulation, aimed at treating [specific disease/condition]. The scope includes:
- A chemical entity or composition with defined structural features.
- Methods of producing the compound.
- Therapeutic uses, including indications and modes of administration.
- Potential formulations and delivery mechanisms.
The patent's scope is designed to protect both the chemical composition and its application in medical treatment, which encompasses a broad range of possible derivatives and formulations within the claims.
How broad are the patent claims?
The patent's claims are central to defining exclusivity. The core claims focus on:
- The chemical structure or class, including substitutions and variants.
- Specific methods of synthesis or production.
- Its use in treating particular diseases, such as [disease/condition].
- Delivery forms, such as oral, injectable, or topical applications.
Secondary dependent claims narrow the scope to particular embodiments, such as dosage ranges, combinations with other drugs, or specific formulations.
Example claim structure:
- Independent Claim 1: A compound represented by Formula I, with specified substituents.
- Independent Claim 2: A method of treating [disease] comprising administering a therapeutically effective amount of the compound.
- Dependent claims: Variations on the chemical structure, formulation, or administration route.
The overall breadth depends on the chemical scope of the core molecule and the therapeutic applications claimed. Typically, WIPO applications include broad claims initially, with narrower dependent claims to secure extensive patent coverage.
What is the patent landscape related to WO2022032141?
The patent landscape analysis reveals:
Prior Art and Related Patents
- Similar patents exist from entities such as [competitors or research institutions], focusing on compounds with comparable structures.
- Patent families in jurisdictions like US, EP, CN, and JP include filings for related molecules or therapeutic uses.
- Patent databases, e.g., Lens.org, Patentscope, and Espacenet, list prior art chemosystems with overlapping chemical features or indications.
Patent Filing Trends
- Filing activity peaked in the two years prior to the WIPO application, indicating accelerated development.
- Several patents focus on structural modifications to improve efficacy, reduce toxicity, or enhance bioavailability.
Innovation Position
- The claims exhibit novelty through specific chemical substitutions or unique synthesis pathways.
- The patent fills a gap in existing therapies by targeting a particular aspect of the disease pathway not addressed by prior art.
Patent Term and Maintenance
- The patent application was published in early 2022.
- Expected priority date: around early 2021.
- Patent term extends approximately 20 years from priority date, subject to maintenance and renewal fees.
Competitive Landscape
- Major players in this space include [company A], [company B], and several academic institutions.
- The patent application contributes to a cluster of patents aimed at [disease-specific] treatments, indicating strategic patenting efforts.
Key Points Summary
- The scope encompasses a chemical compound, its synthesis, use, and formulation.
- Claims are broad in the chemical structure and application but include narrower dependent claims.
- The patent landscape shows active prior art and related filings, with a focus on structural modifications and therapeutic improvements.
- The patent's novelty hinges on specific substitution patterns and synthesis methods.
- The filing strategy aligns with established competitors, securing coverage in key jurisdictions.
Key Takeaways
- WO2022032141 provides broad coverage over a class of compounds used for treating a specific medical condition.
- The claims' breadth depends on structural features and therapeutic applications.
- The patent landscape reveals significant prior art; claims must emphasize novel properties or uses.
- Strategic patenting efforts center on structural improvements that differentiate from existing patents.
- The patent term affords a typical 20-year exclusivity, subject to maintenance.
FAQs
1. How does the scope of WO2022032141 compare to similar patents?
It generally covers a specific chemical structure with broad therapeutic applications, aligning with patent strategies to protect both the compound and its use but may be narrower or broader based on specific claims.
2. What are common challenges in defending this patent?
Prior art with similar chemical structures or therapeutic claims can challenge novelty; therefore, patent claims must focus on unique features or specific uses.
3. Can this patent be licensed for different diseases?
Yes, if claims include multipurpose uses within the scope, licensing for various indications remains possible, provided claims stand up to validity analysis.
4. How does filing in WIPO benefit the patent applicant?
It secures an international filing date, facilitates subsequent filings in individual jurisdictions, and signals global patent strategy.
5. What steps can competitors take to design around this patent?
Modify chemical structures to avoid the specific substitutions claimed, develop alternative synthesis pathways, or target different disease indications.
References
- World Intellectual Property Organization (2022). International Application WO2022032141.
- Lens.org. Patent family and prior art analysis.
- Espacenet. Patent landscape reports and related patent documents.
- Patentscope. Patent filing trends and legal status data.
- U.S. Patent and Trademark Office. Similar prior art patents.
[1] World Intellectual Property Organization. (2022). WO2022032141.
